Effects of a verbenachalcone derivative on neurite outgrowth, inhibition of caspase induction and gene expression

Bioorganic and Medicinal Chemistry Letters

Volumn 15, Issue 4, 2005, Pages 1193-1196

  Yeh, Li An ^a   Padmanaban, Deppa ^a   Ho, Pei ^a   Xing, Xeuchao ^a   Rowley, Patricia ^b   Morse, Lee Jae ^b   Jensen, Roderick V ^b,c   Cuny, Gregory D ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c WESLEYAN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN L; CHALCONE DERIVATIVE; GENE PRODUCT; NERVE GROWTH FACTOR; OLIGONUCLEOTIDE; PROTEIN TYROSINE PHOSPHATASE; RECEPTOR SUBTYPE; SIGMA 1 OPIATE RECEPTOR;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; DRUG STRUCTURE; DRUG TARGETING; ENZYME INDUCTION; ENZYME INHIBITION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE PROBE; NERVE DEGENERATION; NERVE FIBER GROWTH; NEUROPROTECTION; NONHUMAN; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; VALIDATION PROCESS;

EID: 16244375226     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2004.12.001     Document Type: Article

References (29)

1. G.E. Landreth G.J. Siegel B.W. Agranoff R.W. Albers S.K. Fisher M.D. Uhler Basic Neurochemistry: Molecular, Cellular and Medical Aspects 6th ed. 1998 Lippincott Williams & Wilkins New York 383 398 Chapter 19
2. D.R. Kaplan, and F.D. Miller Curr. Opin. Neurobiol. 10 2000 381
3. K.E. Neet, and R.B. Campenot Cell. Mol. Life Sci. 58 2001 1021
4. G.J. Siegel, and N.B. Chauhan Brain Res. Rev. 33 2000 199
5. B. Connor, and M. Dragunow Brain Res. Rev. 27 1998 1
6. S.C. Apfel Clin. Chem. Lab. Med. 39 2001 351
7. S.P. Lad, K.E. Neet, and E.J. Mufson Curr. Drug Targets CNS Neurol. Disord. 2 2003 315
8. S.J. Pollack, and S.J. Harper Curr. Drug Targets CNS Neurol. Disord. 1 2002 59
9. A. Salehi, J.-D. Delcroix, and W.C. Mobley Trends Neurosci. 26 2003 73
10. A. Salehi, J.-D. Delcroix, and D.F. Swaab J. Neural Transm. 111 2004 323
11. Y.-S. Li, K. Matsunaga, R. Kato, and Y. Ohizumi J. Nat. Prod. 64 2001 806
12. X. Xing, D. Padmanaban, L.-A. Yeh, and G.D. Cuny Tetrahedron 58 2002 7903
13. P. Li, K. Matsunaga, K. Yamamoto, R. Yoshikawa, K. Kawashima, and Y. Ohizumi Neurosci. Lett. 273 1999 53
14. A.T. Jacovina, F. Zhong, E. Khazanova, E. Lev, A.B. Deora, and K.A. Hajjar J. Biol. Chem. 276 2001 49350
15. (a) Some cell loss (10-20%) was observed in the presence of 2 (1 and 15 μM), but this did not account for the significant decrease (50-60%) in caspase induction (see supplementary data)
16. (b) No direct inhibition of caspase-3/7 enzymatic activity was observed in the presence of 2 (15 μM)
17. (a) N.H. Lee, K.G. Weinstock, E.E. Kirkness, J.A. Earle-Hughes, R.A. Fuldner, S. Marmaros, A. Glodek, J.D. Gocayne, M.D. Adams, A.R. Kerlavage, C.M. Fraser, and J.C. Venter Proc. Natl. Acad. Sci. U.S.A. 92 1995 8303
18. (b) A 2.6-fold increase in the number of neurites-bearing cells was observed in the presence of NGF (2 ng/mL) plus 2 (15 μM) compared with only NGF (2 ng/mL). This was similar to the results of 2 (15 μM) in Figure 1
19. H. Takemori, Y. Katoh, N. Horike, J. Doi, and M. Okamoto J. Biol. Chem. 277 2002 42334
20. J.P. Liuzzo, S.S. Petanceska, and L.A. Devi Mol. Med. 5 1999 334
21. G. Arslan, E. Kontny, and B.B. Fredholm Neuropharmacology 36 1997 1319
22. R. Joseph, W. Tsang, D. Dou, K. Nelson, and K. Edvardsen Brain Res. 738 1996 32
23. P.K. Parmar, L.C. Coates, J.F. Pearson, R.M. Hill, and N.P. Birch J. Neurochem. 82 2002 1406
24. E. Sharma, and P.J. Lombroso J. Biol. Chem. 270 1995 49
25. T.P. Su, and T. Hayashi Curr. Med. Chem. 10 2003 2073
26. A.M. Van Den Maagdenberg, D. Bachner, J.T. Schepens, W. Peters, J.A. Fransen, B. Wieringa, and W.J. Hendriks Eur. J. Neurosci. 11 1999 3832
27. M. Buschbeck, J. Eickhoff, M.N. Sommer, and A. Ullrich J. Biol. Chem. 277 2002 29503
28. F.L. Watson, H.M. Heerssen, A. Bhattacharyya, L. Klesse, M.Z. Lin, and R.A. Segal Nat. Neurosci. 4 2001 981
29. J.E. Cavanaugh Eur. J. Biochem. 271 2004 2056